Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Trade Show

Ayala Pharmaceuticals Announces Presentation at the European Society for Medical Oncology (ESMO)

Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers, today announced that a poster will be presented at the European Society for Medical Oncology (ESMO), being held in Barcelona, Spain from September 27 to October 1, 2019.

Presentation information is as follows:

Title: ACCURACY a phase (P) 2 trial of AL101, a pan-Notch inhibitor, in recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) patients (pts) with Notch activating mutations (Notchact mut): preliminary safety and efficacy data 
Session Title: Poster Display Session 
Session Date and Time: Monday, September 30, 2019 at 12:00pm to 1:00pm CET 
Presentation Number: 1148P 
Location: Poster Area (Hall 4) 
Presenter: Alan L. Ho, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

About Ayala Pharmaceuticals

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and preclinical studies underway in both solid tumors (AL101) and hematologic malignancies (AL102). Ayala's lead product candidate, AL101, is currently in phase 2 for adenoid cystic carcinoma patients with tumor bearing Notch activating mutations (ACCURACY). For more information, visit www.ayalapharma.com

These press releases may also interest you

at 12:10
Embarcadero (a division of Idera, Inc.), a provider of cross-platform application developer productivity tools, today announced InterBase 2020, the latest release of its flagship database management system including support for tablespaces....

at 12:00
Octane5 announces an agreement with Tottenham Hotspur, the newest addition to its growing number of European football clients. "Tottenham Hotspur selected Octane5's BrandComply Licensing Solution after an extensive market evaluation.  We signed with...

at 12:00
VeChain, the leading enterprise-friendly public blockchain platform, attended The China International Import Expo 2019 (CIIE). Held from November 5 to 10, the CIIE is a major initiative of the Chinese government to give firm support to trade...

at 12:00
Polymer Chemistry Innovations (PCI), a manufacturer of novel polymers and monomers, is awarding one female student $2000 towards her education in a Science, Technology, Engineering, or Math (STEM) higher education program. Students interested in...

at 12:00
STRmixtm ? sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret ? recently played a key role in the trial of a Chicago gang member accused of murdering nine-year-old Tyshawn Lee. Jurors...

at 12:00
Kenko Tokina, Japan's leading manufacturer of premium camera accessories, is releasing the Tokina atx-i 100mm f2.8 Macro FF lens for full-frame DSLR cameras from Nikon and Canon. Distributed in the US exclusively by Kenko Tokina USA, this new lens...

News published on 19 september 2019 at 16:05 and distributed by: